Filing Flows › Evolus (EOLS) › R&D spending
Evolus (EOLS) R&D spending by quarter
Evolus' R&D spending was $2.0M in Q3 2026 (third quarter 2026), +4% from Q2 2026. Over the last 5 quarters it ranged from $1.9M (Q2 2026) to $2.2M (Q1 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $2.0M | +4% | -4% |
| Q2 2026 | $1.9M | -16% | — |
| Q1 2026 | $2.2M | +9% | +1% |
| Q3 2025 | $2.0M | -8% | — |
| Q1 2025 | $2.2M | — | — |
Q3 2026 at a glance
Evolus, Q3 2026: revenue $78.0M (+13% year over year), operating margin -10.8%, net loss $12.5M, operating cash flow −$1.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Evolus' R&D spending?
Evolus' R&D spending was $2.0M in Q3 2026 (third quarter 2026), +4% from Q2 2026.
How has Evolus' R&D spending changed?
Over the last 5 quarters it ranged from $1.9M (Q2 2026) to $2.2M (Q1 2026).